Latest Asset Valuation News

Venus Metals Corporation has issued a second supplementary target’s statement urging shareholders to reject QGold’s increased takeover offer of $0.21 per share, citing significant undervaluation of its key assets and improved financial position.

Venus Metals Corporation urges shareholders to reject QGold's takeover bid, highlighting an independent valuation of its Sandstone Gold Project at $4.39 million and underscoring significant exploration upside.

US1 Critical Minerals has obtained a Federal Court undertaking preventing the transfer or encumbrance of disputed Rare Earth tenements in California, with a trial scheduled for April 2026.

Investor Kjerulf Ainsworth has initiated an unconditional off-market proportional takeover bid for 2.9% of Ainsworth Game Technology shares at $1.30 each, offering shareholders a significant premium and liquidity option.

Thorney Technologies Limited (ASX, TEK) will resume trading on the ASX from 16 December 2025 following the lodgement of its Net Tangible Asset Backing, ending its recent suspension.

Eastern Gas Corporation Limited, a new ASX-listed subsidiary of Pure One Corporation, has lodged a Replacement Prospectus to raise $5.5 million for advancing its Queensland gas projects, targeting commercial production through horizontal drilling and fracture stimulation.

Venus Metals Corporation has issued a firm recommendation to reject QGold Pty Ltd’s unsolicited $0.17 per share takeover offer, arguing it undervalues key assets and offers no premium. The board highlights significant upside potential in its portfolio and warns shareholders against accepting an opportunistic bid.

Eagle Mountain Mining has initiated a non-renounceable entitlement offer to raise nearly $2 million, aiming to accelerate exploration at its Silver Mountain Project in Arizona. The offer includes attaching options and targets eligible shareholders across select countries.

Aspermont Limited reported a 6% rise in revenue and a 12% increase in EBITDA for the year ended September 2025, yet posted a net loss of A$2.576 million. The company’s financial health shows mixed signals amid ongoing operational improvements.

CD Private Equity Fund II reported a reduced net loss of $2.43 million for the half-year to September 2025, supported by $9.45 million in distributions from portfolio realisations. Despite foreign exchange headwinds, the Fund maintains a diversified portfolio and a positive long-term return track record.

CD Private Equity Fund I reported a $2.6 million net loss for the half-year ended 30 September 2025, driven by foreign exchange impacts and fair value adjustments, while distributing 8 cents per unit amid ongoing portfolio realisations.

Ryman Healthcare reported a 13% revenue increase to NZD 413.8 million for H1 2025, yet swung to a significant net loss of NZD 45.2 million and suspended dividends, raising questions about its financial trajectory.